Who are Tears Naturale II Ophthalmic Solution's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): LiquiTears.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tears-naturale-ii-ophthalmic-solution.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Tears Naturale II Ophthalmic Solution — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tears Naturale II Ophthalmic Solution (Tears Naturale II Ophthalmic Solution) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Artificial tear / Lubricating ophthalmic solution. Area: Ophthalmology.

marketed Artificial tear / Lubricating ophthalmic solution Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Tears Naturale II Ophthalmic Solution (Tears Naturale II Ophthalmic Solution) — ORA, Inc.. Tears Naturale II is an artificial tear solution that lubricates and protects the ocular surface by mimicking natural tear composition.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Tears Naturale II Ophthalmic Solution TARGET	Tears Naturale II Ophthalmic Solution	ORA, Inc.	marketed	Artificial tear / Lubricating ophthalmic solution
LiquiTears	LiquiTears	Chakshu Research, Inc.	marketed	Artificial tear / Lubricating ophthalmic solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Artificial tear / Lubricating ophthalmic solution class)

Chakshu Research, Inc. · 1 drug in this class
ORA, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tears Naturale II Ophthalmic Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/tears-naturale-ii-ophthalmic-solution. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab